PuSH - Publikationsserver des Helmholtz Zentrums München

Uusitalo, U.* ; Liu, X.* ; Yang, J.* ; Aronsson, C.A.* ; Hummel, S. ; Butterworth, M.* ; Lernmark, A.* ; Rewers, M.* ; Hagopian, W.* ; She, J.X.* ; Simell, O.* ; Toppari, J.* ; Ziegler, A.-G. ; Akolkar, B.* ; Krischer, J.* ; Norris, J.M.* ; Virtanen, S.M.* ; TEDDY Study Group (*)

Association of early exposure of probiotics and islet autoimmunity in the TEDDY study.

JAMA Pediatr. 170, 20-28 (2016)
Verlagsversion Postprint DOI PMC
Open Access Green
Importance: Probiotics have been hypothesized to affect immunologic responses to environmental exposures by supporting healthy gut microbiota and could therefore theoretically be used to prevent the development of type 1 diabetes mellitus (T1DM)-associated islet autoimmunity. Objective: To examine the association between supplemental probiotic use during the first year of life and islet autoimmunity among children at increased genetic risk of T1DM. Design, Setting, and Participants: In this ongoing prospective cohort study that started September 1, 2004, children from 6 clinical centers, 3 in the United States (Colorado, Georgia/Florida, and Washington) and 3 in Europe (Finland, Germany, and Sweden), were followed up for T1DM-related autoantibodies. Blood samples were collected every 3 months between 3 and 48 months of age and every 6 months thereafter to determine persistent islet autoimmunity. Details of infant feeding, including probiotic supplementation and infant formula use, were monitored from birth using questionnaires and diaries. We applied time-to-event analysis to study the association between probiotic use and islet autoimmunity, stratifying by country and adjusting for family history of type 1 diabetes, HLA-DR-DQ genotypes, sex, birth order, mode of delivery, exclusive breastfeeding, birth year, child's antibiotic use, and diarrheal history, as well as maternal age, probiotic use, and smoking. Altogether 8676 infants with an eligible genotype were enrolled in the follow-up study before the age of 4 months. The final sample consisted of 7473 children with the age range of 4 to 10 years (as of October 31, 2014). Exposures: Early intake of probiotics. Main Outcomes and Measures: Islet autoimmunity revealed by specific islet autoantibodies. Results: Early probiotic supplementation (at the age of 0-27 days) was associated with a decreased risk of islet autoimmunity when compared with probiotic supplementation after 27 days or no probiotic supplementation (hazard ratio [HR], 0.66; 95% CI, 0.46-0.94). The association was accounted for by children with the DR3/4 genotype (HR, 0.40; 95% CI, 0.21-0.74) and was absent among other genotypes (HR, 0.97; 95% CI, 0.62-1.54). Conclusions and Relevance: Early probiotic supplementation may reduce the risk of islet autoimmunity in children at the highest genetic risk of T1DM. The result needs to be confirmed in further studies before any recommendation of probiotics use is made.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Glutamic-acid Decarboxylase; Gut Microbiota; Intestinal Microbiota; Immune-system; Human Infant; Human-milk; Children; Risk; Permeability; Diseases
ISSN (print) / ISBN 2168-6203
e-ISSN 1538-3628
Zeitschrift JAMA Pediatrics
Quellenangaben Band: 170, Heft: 1, Seiten: 20-28 Artikelnummer: , Supplement: ,
Verlag American Medical Association
Verlagsort Chicago
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research Type 1 (IDF)